Welcome to our dedicated page for Vita Coco Company SEC filings (Ticker: COCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
From the coconut farms of the Philippines to refrigerators across the U.S., Vita Coco turns raw coconuts into a global hydration franchise. That supply chain—and the social commitments behind it—surface in every SEC document. If you’ve searched for “Vita Coco SEC filings explained simply” or wondered how sustainability costs flow through the P&L, this page delivers the answers.
Here you will find the “Vita Coco annual report 10-K simplified” to track segment growth in The Americas, the “Vita Coco quarterly earnings report 10-Q filing” that reveals coconut cost inflation, and the “Vita Coco 8-K material events explained” whenever sourcing disruptions arise. Need to monitor management moves? Our dashboard surfaces “Vita Coco insider trading Form 4 transactions,” “Vita Coco Form 4 insider transactions real-time,” and “Vita Coco executive stock transactions Form 4” the moment they hit EDGAR. Corporate governance questions? Scan the “Vita Coco proxy statement executive compensation” to see how bonus targets align with carbon reduction goals. Each document includes concise summaries and real-time alerts.
Stock Titan’s AI distills every note into clear language, so “understanding Vita Coco SEC documents with AI” means you can jump straight to coconut-water revenue, cash flow, or sustainability metrics. Receive instant notifications, compare “Vita Coco earnings report filing analysis” quarter over quarter, and export numbers directly to your models. Save hours and make confident decisions with complete, up-to-date information.
Jane Prior, Chief Marketing Officer of Vita Coco Company, Inc. (COCO), reported insider activity showing simultaneous option exercise and open-market sales on 09/17/2025. She acquired 10,000 shares at $10.178 per share (Code M) and sold 10,000 shares pursuant to a Rule 10b5-1 trading plan at a weighted average price of $42.043, with sale prices ranging from $42.00 to $42.19. After these transactions she beneficially owned 123,666 shares. The filing lists multiple outstanding non-qualified stock options at various exercise prices and vesting schedules, including 33,750 currently exercisable shares and several tranches vesting through 2035.
Insider sale under a Rule 10b5-1 plan: Liran Ira, a director of Vita Coco Company, Inc. (COCO), reported selling 50,000 shares of the issuer's common stock on 09/17/2025 at a weighted average price of $42.003 per share. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan. After the reported transactions, the form discloses 598,341 shares held directly and 692,579 shares held indirectly through the Ira Liran 2012 Family Trust. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/19/2025.
Michael Kirban, Executive Chairman of Vita Coco Company, Inc. (COCO), reported an open-market sale of 30,000 shares of common stock executed under a Rule 10b5-1 trading plan at a weighted average price of $41.719 per share. The Form 4 shows the reporting person retains significant holdings: 1,549,049 shares indirectly held by the Michael Kirban 2010 Trust, 615,681 shares indirectly held by the Michael Kirban Revocable Trust, and 127,629 shares directly held. Multiple stock options across various strike prices and vesting schedules are also disclosed, including fully exercisable options and several tranches that vest over coming years.
Jonathan Burth, Chief Operating Officer of Vita Coco Company, Inc. (COCO), reported related transactions on 09/17/2025. He acquired 16,827 shares by exercising non-qualified stock options at an exercise price of $10.178 per share and sold 16,827 shares pursuant to a Rule 10b5-1 trading plan at a weighted average price of $42.546 per share (sales ranged from $42.50 to $42.73). Following these transactions his beneficial ownership of common stock decreased from 92,954 shares to 76,127 shares. The filing also lists multiple outstanding non-qualified stock options exercisable and unexercisable, with strike prices ranging from $10.178 to $33.36 and various vesting schedules.
Verlinvest Beverages SA, reporting as an officer of Vita Coco Company, Inc. (COCO), sold 3,000,000 shares of the issuer's common stock on 09/17/2025 at a price of $40.77 per share. The filing lists 4,097,161 shares beneficially owned following the transaction, held directly. The sale is described as a block sale executed under Rule 144 to an unaffiliated financial institution. The Form 4 is signed by Axelle Henry on 09/19/2025 and indicates the reporting person is a former 10% owner and an officer.
Martin Roper, a director and the CEO of Vita Coco Company, Inc. (COCO), reported multiple sales of common stock on September 16–17, 2025 effected under a Rule 10b5-1 trading plan. The Form 4 shows both direct and indirect dispositions: direct sales by the reporting person and sales of shares held in related family trusts. Prices reported are weighted averages around $40.00–$40.54 per share. The filing also discloses substantial stock option holdings that are largely vested and exercisable at strike prices ranging from $10.178 to $32.78, with multiple option grants representing significant potential common shares.
Corey Baker, listed as Chief Financial Officer of Vita Coco Company, Inc. (COCO), reported a series of transactions on 09/16/2025–09/18/2025. The filings show three separate acquisitions of 1,000 shares each at $16.91 and three corresponding sales of 1,000 shares each at $40. After those transactions the reporting person held 38,754 shares of common stock.
The Form 4 also discloses exercises or holdings of multiple non-qualified stock options with strike prices ranging from $16.91 to $33.36 covering in aggregate thousands of underlying shares (for example, 13,481 shares at $24.35 and 13,218 shares at $33.36). The sales of common stock were effected pursuant to a Rule 10b5-1 trading plan, as stated in the filing.
Form 144 notice filed for Vita Coco Company, Inc. (COCO). The filer intends to sell 3,000,000 shares of common stock through Morgan Stanley & Co. LLC on or about 09/17/2025, with an aggregate market value of $126,900,000. The shares were acquired on 12/21/2016 via a pre-IPO investment originally held by Verlinvest SA and later transferred to Verlinvest Beverages SA; payment was in cash. The issuer has 56,822,981 shares outstanding per the filing. The notice states there were no securities sold by the reporting person in the past three months and includes the required representation that the selling person is not aware of undisclosed material adverse information.
Vita Coco Company, Inc. (COCO) filed a Form 144 reporting proposed sale of 20,000 common shares following an exercise of stock options on the same day. The securities are to be sold through Morgan Stanley Smith Barney LLC on NASDAQ with an aggregate market value reported as $799,600 and approximately 56,822,981 shares outstanding. The filer reports the acquisition and payment occurred on 09/17/2025 (cash payment), and discloses a recent 10b5-1 sale of 10,000 shares on 09/12/2025 generating $400,032 in gross proceeds. The filing includes the usual representation about absence of undisclosed material information.
Vita Coco Company, Inc. (COCO) notice records a proposed sale under Rule 144 and recent 10b5-1 transactions by an insider. The filer plans to sell 20,000 common shares through Morgan Stanley Smith Barney at an aggregate market value of $799,600, representing securities outstanding of 56,822,981 shares, with an approximate sale date of 09/17/2025.
The securities were acquired on 09/17/2025 by exercise of stock options and paid in cash. The filing also discloses two prior 10b5-1 sales this year: 10,000 shares on 07/07/2025 for $380,178 and 10,000 shares on 09/12/2025 for $400,019.
FAQ
What is the current stock price of Vita Coco Company (COCO)?
What is the market cap of Vita Coco Company (COCO)?
